October 28, 2008

Align Technology Announces Third Quarter Fiscal 2008 Results

SANTA CLARA, Calif., Oct 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Align Technology, Inc. (Nasdaq: ALGN) today reported financial results for the third quarter of fiscal 2008, ended September 30, 2008.

Total net revenues for the third quarter of fiscal 2008 (Q3 08) were $75.2 million compared to $71.5 million reported in the third quarter of 2007 (Q3 07) and compared to $79.9 million reported in the second quarter of 2008 (Q2 08).

On a generally accepted accounting principles (GAAP) basis, net profit for Q3 08 was $5.2 million, or $0.08 per diluted share. This is compared to net profit of $9.5 million, or $0.13 per diluted share in Q3 07, and net profit of $4.0 million, or $0.06 per diluted share in Q2 08. Stock-based compensation expense included in Q3 08 net profit was $4.4 million, compared to $3.4 million in Q3 07, and $4.8 million in Q2 08.

"I am pleased with our results during these challenging times," said Thomas M. Prescott, president and CEO of Align Technology. "We are committed to continuing investment in new products and our key strategic initiatives while lowering our overall cost structure, which will position the Company for renewed growth and profitability as the environment improves."

Non-GAAP net profit for Q3 08 was $7.4 million, or $0.11 per diluted share. This is compared to non-GAAP net profit of $9.5 million, or $0.13 per diluted share in Q3 07, and non-GAAP net profit of $4.0 million, or $0.06 per diluted share in Q2 08.

Non-GAAP financial measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. A detailed reconciliation between GAAP and non-GAAP information is contained in the tables following the financial tables of this release.

    Q3 08 Operating Results

    Key GAAP Operating Results                 Q3 08       Q2 08      Q3 07
    Gross Margin                                75.0%       74.7%      74.6%
    Operating Expense                          $50.7M      $55.8M     $44.9M
    Operating Margin                             7.6%        4.8%      11.7%
    Net Profit                                  $5.2M       $4.0M      $9.5M
    Earnings Per Diluted Share (EPS)           $0.08       $0.06      $0.13

    Key Non-GAAP Operating Results             Q3 08       Q2 08      Q3 07
    Non-GAAP Operating Expense                 $48.5M      $55.8M     $44.9M
    Non-GAAP Net Profit                         $7.4M       $4.0M      $9.5M
    Non-GAAP Earnings Per Diluted Share (EPS)  $0.11       $0.06      $0.13

Liquidity and Capital Resources

As of September 30, 2008, Align had $114.3 million in cash, cash equivalents, and short term marketable securities compared to $127.9 million as of December 31, 2007. During Q3 08, Align purchased 930,373 shares at an average price of $12.62 per share for a total of $11.7 million. There remains $10.7 million under the Company's existing stock repurchase authorization.

Key Business Metrics

The following table highlights business metrics for Align's third quarter of 2008. Additional historical information is available on the Company's website at http://investor.aligntech.com.

    Revenue by Channel:                        Q3 08     Q3 08/Q2   Q3 08/Q3
                                                            08         07
                                                        % Change   % Change
    U.S. Orthodontists                         $22.3       (4.2%)     (0.8%)
    U.S. GP Dentists                           $35.2       (3.9%)      1.0%
    International                              $15.1       (8.0%)     31.1%
    Training and Other                          $2.6      (28.3%)     (1.3%)
    Total Revenue                              $75.2       (5.9%)      5.2%

    Average Selling Price (ASP):               Q3 08     Q3 08/Q2   Q3 08/Q3
                                                            08         07
                                                        % Change   % Change

    Total Worldwide Blended ASP               $1,390        0.0%       5.3%
    Total Worldwide ASP excluding
     Invisalign Express                       $1,500        0.0%       4.9%
    U.S. Orthodontists Blended ASP            $1,290        0.0%       4.9%
    U.S. GP Dentists Blended ASP              $1,360        1.5%       3.8%
    International                             $1,660       (2.4%)      5.1%

    Number of Cases Shipped:                   Q3 08     Q3 08/Q2   Q3 08/Q3
                                                            08         07
                                                        % Change   % Change

    U.S. Orthodontists - Full Invisalign      15,000        1.1%      (1.1%)
    U.S. Orthodontists - Invisalign Express    2,970       (8.6%)     (5.1%)
    U.S. GP Dentists - Full Invisalign        21,070       (4.8%)     (3.7%)
    U.S. GP Dentists - Invisalign Express      4,620       (7.0%)      0.4%
    International- Full Invisalign             8,950       (6.0%)     25.0%
    International- Invisalign Express            190       18.8%      46.2%
    Total Cases Shipped                       52,800       (3.8%)      1.4%

    Number of Doctors Cases were Shipped to:   Q3 08
    U.S. Orthodontists                         3,730
    U.S. GP Dentists                          10,920
    International                              2,900
    Total Doctors Cases were Shipped to
     Worldwide                                17,550

    Number of Doctors Trained Worldwide:       Q3 08    Cumulative
    U.S. Orthodontists                            90      8,600
    U.S. GP Dentists                           1,030     31,300
    International                                330     13,670
    Total Doctors Trained Worldwide            1,450     53,570

    Multiple Case Doctors (Cumulative as of):  Q3 08
    U.S. Orthodontists                          90.6%
    U.S. GP Dentists                            86.4%
    International                               77.3%

    Doctors Starting Invisalign Treatment
     (Cumulative as of):                       Q3 08
    U.S. Orthodontists                         7,030
    U.S. GP Dentists                          24,900
    International                              7,740
    Total Doctors Starting Invisalign
     Treatment                                39,670

    Doctor Utilization Rates*:                 Q3 08       Q2 08      Q3 07
    U.S. Orthodontists                           4.8        4.9        4.9
    U.S. GP Dentists                             2.4        2.5        2.6
    International                                3.2        3.3        3.1
    Total Utilization Rate                       3.0        3.1        3.2

    * Utilization = # of cases/# of doctors to whom cases were shipped

Business Outlook

For the fourth quarter of fiscal 2008 (Q4 08), Align Technology expects net revenues to be in a range of $72.5 million to $76.5 million. GAAP earnings per diluted share for Q4 08 is expected to be in a range of $0.01 to $0.03. Non-GAAP earnings per diluted share for Q4 08 is expected to be in a range of $0.06 to $0.09. Stock-based stock compensation expense for Q4 08 is expected to be approximately $4.1 million.

For fiscal 2008, Align Technology expects net revenues to be in a range of $302.5 million to $306.5 million. The Company continues to expect the increase in deferred revenue for fiscal 2008 to be in the range of $5 million to $8 million primarily associated with new products, which will be recognized in future periods, bringing the Company's total deferred revenue balance at the end of 2008 to a range of $17 million to $20 million. GAAP earnings per diluted share for fiscal 2008 is expected to be in a range of $0.22 to $0.24. Non-GAAP earnings per diluted share for fiscal 2008 is expected to be in a range of $0.31 to $0.33. Stock-based compensation expense for fiscal 2008 is expected to be approximately $17.3 million.

A more comprehensive business outlook is available following the financial tables of this release.

Restructuring Announcement

On October 23, 2008 Align, announced a restructuring plan to increase efficiencies across the organization and lower the Company's overall cost structure. The restructuring plan includes a total reduction of 110 full time headcount in Santa Clara, California. As part of these actions, Align will record a restructuring charge estimated to be approximately $5 million, of which approximately $3.5 million will be realized in Q4 08 and the remainder over the first half of 2009. This is in addition to the restructuring charge that the Company announced in July 2008. For more information, please see Align's press release titled, "Align Technology Announces Restructuring Plan."

Align Web Cast and Conference Call

Align Technology will host a conference call today, October 28, 2008 at 4:30 p.m. ET, 1:30 p.m. PT, to review its third quarter fiscal 2008 results, discuss future operating trends and business outlook. The conference call will also be web cast live via the Internet. To access the web cast, go to the "Events & Presentations" section under Company Information on Align Technology's Investor Relations web site at http://investor.aligntech.com. To access the conference call, please dial 201-689-8341 approximately fifteen minutes prior to the start of the call. If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available for approximately 12 months. Additionally, a telephonic replay of the call can be accessed by dialing 877-660-6853 with account number 292 followed by # and conference number 289246 followed by #. The replay must be accessed from international locations by dialing 201-612-7415 and using the same account and conference numbers referenced above. The telephonic replay will be available through 5:30 p.m. ET on November 11, 2008.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.

About non-GAAP Financial Measures

To supplement our consolidated financial statements and our business outlook, we use the following non-GAAP financial measures: non-GAAP operating expenses, non-GAAP net profit, non-GAAP earnings per share, which exclude the effect of charges associated with the restructuring. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. For more information on these non-GAAP financial measures, please see the tables captioned "Business Outlook Summary" included at the end of this release.

We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our "core operating performance". Management believes that "core operating performance" represents Align's performance in the ordinary, ongoing and customary course of its operations. Accordingly, management excludes from "core operating performance" certain expenses and expenditures that may not be indicative of our operating performance including discrete cash charges that are infrequent or one-time in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal evaluation of period-to-period comparisons. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and (2) they are provided to and used by our institutional investors and the analyst community to facilitate comparisons with prior and subsequent reporting periods.

Forward-Looking Statement

This news release, including the tables below, contains forward-looking statements, including statements regarding, the expected amount of and timing of the charges to be incurred in connection with the restructuring and Align's anticipated financial results and certain business metrics for the fourth quarter and full year of 2008, including anticipated revenue and deferred revenue, gross profit, gross margin, operating expense, net profit, earnings per share, percentage of revenue by channel, case shipments and average selling prices. Forward-looking statements contained in this news release and the tables below relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, failure to achieve the expected cost savings and efficiencies related to the restructuring, including a delay in the implementation of the relocation of certain customer facing organizations from Santa Clara, California to Costa Rica and greater than anticipated costs resulting from the relocation, changes in the size of the expected restructuring charge, loss of key personnel responsible for interpreting the relocation in a timely manner, failure to effectively manage the relocation resulting in decreased customer service levels, the possibility that the development and release of new products does not proceed in accordance with the anticipated timeline, the possibility that the market for the sale of these new products may not develop as expected, the risks relating to Align's ability to sustain or increase profitability or revenue growth in future periods while controlling expenses, continued customer demand for Invisalign and new products, changes in consumer spending habits as a result of, among other tings, prevailing economic conditions, levels of employment, salaries and wages and consumer confidence, the timing of case submissions from our doctors within a quarter, acceptance of Invisalign by consumers and dental professionals, Align's third party manufacturing processes and personnel, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to protect its intellectual property rights, competition from manufacturers of traditional braces and new competitors, Align's ability to develop and successfully introduce new products and product enhancements, and the loss of key personnel. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the fiscal year ended December 31, 2007, which was filed with the Securities and Exchange Commission on February 26, 2008. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

     Investor Relations Contact         Press Contact
     Shirley Stacy                      Shannon Mangum Henderson
     Align Technology, Inc.             Ethos Communication, Inc.
     (408) 470-1150                     (678) 540-9222
     sstacy@aligntech.com               align@ethoscommunication.com

    (in thousands, except per share data)
                                    Three Months Ended    Nine Months Ended
                                    Sept. 30, Sept. 30,  Sept. 30, Sept. 30,
                                       2008      2007       2008      2007

    Net revenues                     $75,173   $71,451  $ 229,851  $211,815

    Cost of revenues                  18,766    18,132     58,617    55,908

    Gross profit                      56,407    53,319    171,234   155,907

    Operating expenses:
    Sales and marketing               28,214    24,226     88,737    71,729
    General and administrative        14,395    13,949     45,905    38,014
    Research and development           5,918     6,749     20,214    19,117
    Restructuring                      2,189         -      2,189         -
    Patients First Program                 -         -          -    (1,796)

    Total operating expenses          50,716    44,924    157,045   127,064

    Profit from operations             5,691     8,395     14,189    28,843

    Interest and other income, net       264     1,108      1,673     2,243

    Profit before income taxes         5,955     9,503     15,862    31,086

    Provision for income taxes         (798)      (43)    (1,371)    (1,030)

    Net profit                        $5,157    $9,460    $14,491   $30,056

    Net profit per share
      - basic                          $0.08     $0.14      $0.21     $0.45
      - diluted                        $0.08     $0.13      $0.21     $0.42

    Shares used in computing net
     profit per share
      - basic                         67,367    67,970     68,330    66,709
      - diluted                       68,704    72,230     69,906    71,058

    (in thousands)

                                                   September 30,  December 31,
                                                         2008         2007

    Current assets:
    Cash and cash equivalents                          $79,756      $89,140
    Marketable securities, short-term                   34,499       38,771
    Accounts receivable, net                            48,872       44,850
    Inventories, net                                     3,015        2,910
    Other current assets                                 7,412        8,846
      Total current assets                             173,554      184,517

    Property and equipment, net                         29,568       25,320
    Goodwill and intangible assets, net                  8,966       11,093
    Other long-term assets                               4,432        1,831

      Total assets                                    $216,520     $222,761


    Current liabilities:
    Accounts payable                                    $7,485       $9,222
    Accrued liabilities                                 33,877       39,875
    Deferred revenues                                   15,380       12,362
      Total current liabilities                         56,742       61,459

    Other long term liabilities                            124          148

      Total liabilities                                 56,866       61,607

    Total stockholders' equity                         159,654      161,154

        Total liabilities and stockholders' equity    $216,520     $222,761


    Reconciliation of GAAP to Non-GAAP
     Operating Expenses
     (in thousands)
                                                    Three Months Ended
                                             September       June    September
                                                 30,          30,        30,
                                                2008         2008       2007

    GAAP Operating expenses                   $50,716      $55,787    $44,924
      Restructuring Cost                       (2,189)           -          -
    Non-GAAP Operating expenses               $48,527      $55,787    $44,924

    Reconciliation of GAAP to Non-GAAP
     Net Profit (Loss)
     (in thousands, except per share amounts)
                                                    Three Months Ended
                                             September       June    September
                                                 30,          30,        30,
                                                2008         2008       2007

    GAAP Net profit                            $5,157       $4,030     $9,460
      Restructuring                             2,189            -          -
      Tax effect on Restructuring                  85            -          -

    Non-GAAP Net profit                        $7,431       $4,030     $9,460

    Diluted Net profit per share:
      GAAP                                      $0.08        $0.06      $0.13
      Non-GAAP                                  $0.11        $0.06      $0.13

    Shares used in computing diluted net
     profit per share                          68,704       69,916     72,230


The outlook figures provided below and elsewhere in this press release are approximate in nature since Align's business outlook is difficult to predict. Align's future performance involves numerous risks and uncertainties and the company's results could differ materially from the outlook provided. Some of the factors that could affect Align's future financial performance and business outlook are set forth under ''Forward Looking Information'' above in this press release. This outlook excludes the effects of any stock repurchases.

    Financials (including reconciliation of GAAP to non-GAAP financial
    (in millions, except per share amounts and percentages)

                                                Q4 2008
                                GAAP          Adjustment(a)       Non-GAAP

    Net Revenue             $72.5 - $76.5                       $72.5 - $76.5

    Gross Margin            72.5% - 73.0%                       72.5% - 73.0%

    Operating Expenses      $52.1 - $53.6        $4.0        (a)$48.1 - $49.6

    Net Profit %               1% - 3%             5%              6% - 8%

    Net Profit per
     Diluted Share          $0.01 - $0.03    $0.05 - $0.06      $0.06 - $0.09
    - $0.33

    Stock Based
     Compensation Expense:
    Cost of Revenues            $0.4                                $0.4
    Operating Expenses          $3.7                                $3.7
    Total Stock Based
     Compensation Expense       $4.1                                $4.1

    (a) Restructuring

    Business Metrics:
                              Q4 2008
    Case Shipments          52.5K - 55.0K
    Cash                    $115M - $120M
    DSO                        ~59 days
    Capex                   $3.0M - $5.0M
     & Amortization         $2.0M - $3.0M
    Diluted Shares
     Outstanding                68.1

                                                FY 2008
                              FY 2008         Adjustment(a)       Non-GAAP

    Net Revenue            $302.5 - $306.5                     $302.5 - $306.5

    Gross Margin            74.0% - 74.1%                       74.0% - 74.1%

    Operating Expenses     $209.1 - $210.6       $6.2       (a)$202.9 - $204.4

    Net Profit %               5% - 6%             2%              7% - 8%

    Net Profit per
     Diluted Share          $0.22 - $0.24        $0.09          $0.31 - $0.33

    Stock Based Compensation
    Cost of Revenues            $1.7                                $1.7
    Operating Expenses         $15.6                               $15.6
    Total Stock Based
     Compensation Expense      $17.3                               $17.3

    Increase in Deferred
     Revenue                 $5.0 - $8.0                         $5.0 - $8.0

    Total Deferred
     Revenue Balance        $17.0 - $20.0                       $17.0 - $20.0

    (a) Restructuring

    Business Metrics:
                               FY 2008
    Case Shipments         211.9K - 214.4K
    Cash                    $115M - $120M
    DSO                        ~59 days
    Capex                  $15.0M - $17.0M
     & Amortization        $13.0M - $14.0M
    Diluted Shares
     Outstanding                69.4

SOURCE Align Technology, Inc.


Copyright (C) 2008 PR Newswire. All rights reserved

News Provided by COMTEX

Close window | Back to top

Copyright 2018 Align Technology, Inc.